Financials
- Market Capitalization 523.81 M
- Employee 149
- Founded 2018
- CEO N/A
- Website www.kyvernatx.com
- Headquarter Delaware, United States
- FIGI BBG00RCYMHR1
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.58
市销率
-6 934.07
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2876 | CABA Cabaletta Bio, Inc. - Common Stock | 3.23 USD | -4.44% | 0.00% | +18.75% | +113.91% | 547.63 M USD | ||
| 2894 | ENTX Entera Bio Ltd. - Ordinary Shares | 3.04 USD | -1.30% | -8.71% | -5.59% | +52.00% | 526.35 M USD | ||
| 2910 | EDIT Editas Medicine, Inc. - Common Stock | 3.32 USD | +0.61% | +7.79% | +27.69% | +25.28% | 509.89 M USD | ||
| 2919 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.89 USD | -5.12% | -3.23% | +12.75% | +53.75% | 478.57 M USD |